← Russell 3000 cross-section

MD Pediatrix Medical Group, Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-08-04, not restated
Healthcare

Scale

Market cap
$2.2bn
Revenue TTM
$2.0bn
Net income TTM
$175m
Free cash flow
Composite score
76.4
Sector rank
#1592

Valuation

P / E
12.5
EV / EBITDA
7.5
EV / sales
0.9
FCF yield
Earnings yield vs 10-yr
3.28pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
9.0%
EBITDA margin
12.2%
ROE
19.8%
ROIC
45.2%
Revenue growth
0.5%

Insider activity, last 90 days

Net open-market
$0.00m
Buyers
0
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

During the three months ended June 30, 2026, the percentage of our patient service revenue being reimbursed under government-sponsored or government-funded healthcare programs (“GHC Programs”) decreased as compared to the three months ended June 30, 2025. Results of Operations Three Months Ended June 30, 2026 as Compared to Three Months Ended June 30, 2025 Our net revenue was $487.8 million for the three months ended June 30, 2026, as compared to $468.8 million for the same period in 2025. …Pediatrix Medical Group, Inc., 10-Q, period ended 2026-06-30, filed 2026-08-04

Read the full passage →